(Q42468979)

1 November 2017

Induced pluripotent stem cells from human revertant keratinocytes for the treatment of epidermolysis bullosa (English)

1 reference

Human Induced Pluripotent Stem Cells

1 November 2017

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Noriko Umegaki-Arao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Anna M G Pasmooij

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jane E Cerise

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Zongyou Guo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Brynn Levy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Antoni Gostyński

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Lisa R Rothman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Marcel F Jonkman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Angela M Christiano

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

1 November 2014

1 reference

Science Translational Medicine

1 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

264ra164

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25429057%20AND%20SRC:MED&resulttype=core&format=json

Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Revertant mosaicism in human genetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Spontaneous reversion of novel Lesch-Nyhan mutation by HPRT gene rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Cause-specific risks of childhood death in inherited epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Novel molecular therapies for heritable skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

TALEN-based gene correction for epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Bone marrow transplantation for recessive dystrophic epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Multiple correcting COL17A1 mutations in patients with revertant mosaicism of epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Revertant mosaicism--patchwork in the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

New lessons learned from disease modeling with induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Genome editing in induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Successful therapeutic transplantation of revertant skin in epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Generation of induced pluripotent stem cells using recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342

Revertant Mosaicism in Kindler Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3009342